Navigation Links
Cancer Research 'David' Hopes to Slay 'Cancer Goliath'
Date:3/9/2009

PHOENIX, March 9 /PRNewswire-USNewswire/ -- What if after 100 years of searching by major institutions and government agencies for the conquest of cancer, a small, unheralded, non-profit organization could become the "David" that helped slay the Cancer Goliath?

Improbable? Perhaps. Impossible? No. Remember the two young men who from their garage revolutionized the computer industry?

CHAI Foundation for Medical Research & Life Extension, Inc. (CHAI Foundation), a 501(c)(3) non-profit cancer research organization in Phoenix, AZ, was established eleven (11) years ago to find effective but less toxic forms of cancer treatment. They have now confirmed an anti-cancer material which they gave the laboratory name, Protein-B(LPN).

Protein-B(LPN) has been found to enhance the immune system by particularly enhancing Beta cells, causing them to strengthen specific anti-cancer antibodies.

The active material is a biological agent resulting from a pre-treated serum injected into a particular large animal. The serum causes the animal's system to create an immune-stimulating antibody which in turn is injected into a special strain of mice that has naturally occurring breast cancer. (The injected pre-treated serum into the large animal appears to give the animal lifetime immunity to cancer).

Protein-B(LPN) has shown effectiveness on a number of organ sites in both man and animals toward the conquest of cancer without the toxicity normally associated with today's modalities. Please see: www.chaifoundation.org

"It has been the passion of my life since childhood to help bring about the conquest of cancer," said Eroca Daniel, CEO of CHAI Foundation.

The anti-cancer material was clinically tested outside the U.S. by Dr. Eric R. Brown on patients exhibiting lesions in one or more sites of the breast, skin, liver, lung, spine, pancreas, prostate, ovary, and stomach. In addition, some effectiveness was seen in an instance of lymphoid leukemia, and one of a glioma of the ocular nerve. These tests preceded his more recent death due to an unfortunate accident.

As a small Foundation hard hit by the untimely death of their world-class Research Director and Microbiologist, Eric R. Brown, M.D., Ph.D. (Virology & Immunology) et al, and one who does not maintain its own laboratory, CHAI Foundation's Board is exploring collaboration possibilities to help complete and bring to fruition the promising findings of this cancer treatment breakthrough for amelioration, reduction, and/or elimination of malignant tumors.

It is also theorized that with further study the material could be made into a vaccine.

CHAI Foundation believes they know what the anti-cancer material is, and possibly where it originates.

Additional funding as well as collaboration is needed to:

(1) recreate the formula to conduct new studies

(2) conduct a viability test on a special endogenous mouse model comparing it to earlier test results on this model, and

(3) carry out a new clinical test on some 50 U.S. patients.

CHAI Foundation is unique in that for the past eleven (11) years since its founding, all professionals have kindly and generously volunteered their services to the conquest of cancer.

Said Maria Crimi Speth, the Phoenix attorney for CHAI Foundation, "Jaburg & Wilk has been happy to help CHAI Foundation with some of their legal needs over the last several years while they pursue their goal for the eradication of cancer."

A Preliminary Patent Application has been filed through Sonnenschein Nath & Rosenthal.

A Tax Deductable Donation can be sent to P.O. Box 30603 Phoenix, Arizona 85046.

For further information, you can contact Eroca Daniel at CHAI Foundation 602-996-6291 between 9:00 AM - 5:00 PM (MST), or email them at inquiries@chaifoundation.org.


'/>"/>
SOURCE CHAI Foundation for Medical Research & Life Extension, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Freezing Prostate Cancer Does a Mans Body Good
2. Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors
3. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
4. SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists
5. CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
6. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
7. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
8. Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year
9. New Cancer Treatment Stops Aggressive Sarcomas
10. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
11. Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... , Feb. 17, 2017   Parker ... protecting the rights of victims injured by medical ... regulators to call for better reporting. Congress required ... Safety concerns involving power morcellators and duodenoscopes ... to investigate how hospitals report injuries and deaths ...
(Date:2/17/2017)... February 17, 2017 Cryoablation, Electrical, Endometrial Hydrothermal, ... The global ablation technologies market is expected to grow at a ... The market is expected to grow at a CAGR of 9.5% ... 2016, and $9.05bn in 2026. ... How this report will benefit you Read on ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
Breaking Medicine Technology:
(Date:2/17/2017)... Tampa, FL (PRWEB) , ... February 17, 2017 ... ... a premier sponsor and exhibitor at Molecular Medicine Tri-Conference February 20 – 22 ... through Wednesday, Inspirata will showcase its anatomic and molecular pathology workflow solution, as ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists ... from February 21 - 23 in Beaver Creek, CO. It was announced today by ... second year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... services and financial planning assistance to families and business owners in the greater ... LifeNet 4 Families organization. , For more than 30 years, LifeNet 4 ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
(Date:2/16/2017)... ... 2017 , ... The Price Agency, a Jefferson County-based firm ... the Birmingham area, is announcing an ongoing charity event to help raise support ... son, Anius. , Anius is medically complex with diagnoses consisting and not limited ...
Breaking Medicine News(10 mins):